

Core Viewpoint - The Honghu Fund, established by China Life and Xinhua Insurance, has successfully completed its initial investment phases and is progressing well in its third phase, with a total approved scale of 110 billion yuan [1][3]. Summary by Sections Fund Progress - As of mid-2023, the first phase of the Honghu Fund has completed its investment tasks and achieved good returns. The second phase has also completed its main investment work by the end of Q2 2023, while the third phase commenced in early July and is progressing smoothly [1]. Fund Structure - The Honghu Fund consists of three phases with a total approved scale of 110 billion yuan. The first phase has a scale of 50 billion yuan, with both China Life and Xinhua Insurance contributing 25 billion yuan each. The second phase has a scale of 20 billion yuan, with each insurer contributing 10 billion yuan. The third phase has an approved scale of 40 billion yuan, with two products under it [2][3]. Investment Strategy - The investment scope of the Honghu Fund includes large listed companies that are constituents of the CSI A500 index, focusing on companies with good governance, stable operations, consistent dividends, and good liquidity. The fund aims to maintain the long-term stability of the capital market and optimize asset allocation [3]. Performance Metrics - As of June 30, the first phase of the Honghu Fund, named Honghu Zhiyuan (Shanghai) Private Investment Fund Co., Ltd., reported total assets of 57.112 billion yuan, net assets of 55.684 billion yuan, operating income of 1.203 billion yuan, operating profit of 1.175 billion yuan, and net profit of 968 million yuan for the first half of the year [5]. Future Outlook - The fund management emphasizes adherence to investment discipline, deepening research, optimizing asset allocation, and achieving a balance between functionality and profitability in the long term [4].